Back to Search
Start Over
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
- Source :
-
Chest [Chest] 2017 Dec; Vol. 152 (6), pp. 1266-1275. Date of Electronic Publication: 2017 Aug 16. - Publication Year :
- 2017
-
Abstract
- Background: The clinical characteristics and outcomes of asymptomatic patients with paroxysmal or persistent/permanent atrial fibrillation (AF) are largely unknown.<br />Methods: The Fushimi AF Registry is a community-based prospective survey of patients with AF who visited the participating medical institutions in Fushimi-ku, Japan. We investigated the clinical characteristics and outcomes of asymptomatic vs symptomatic patients in the paroxysmal AF (PAF; n = 1,837) and persistent/permanent (sustained atrial fibrillation [SAF]; n = 1,912) subgroups.<br />Results: In the PAF group, asymptomatic patients were older (asymptomatic vs symptomatic group, 74.1 vs 71.1 years of age; P < .01), more often male (62.1% vs 55.6%; P < .01), and had a higher CHA <subscript>2</subscript> DS <subscript>2</subscript> -VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, history of stroke, vascular disease, age 65-74 years, and female sex) score (mean, 3.37 ± 1.73 vs 2.99 ± 1.63; P < .01), whereas the prevalence of major co-morbidities and CHA <subscript>2</subscript> DS <subscript>2</subscript> -VASc scores were comparable in the SAF group. Multivariable analysis indicated that age (≥ 75 years), history of stroke/systemic embolism, male sex, and chronic kidney disease were independent determinants of asymptomatic status in the PAF group, whereas age was nonsignificant in the SAF group. During the follow-up period, all-cause mortality was significantly higher (hazard ratio, 1.71 [95% CI, 1.31-2.29]; P < .01) in asymptomatic patients compared with symptomatic patients in the PAF group, whereas it was comparable in the SAF group.<br />Conclusions: Asymptomatic clinical status is associated with older age, male sex, more co-morbidities with a higher stroke risk profile, and a higher incidence of all-cause death in patients with PAF; these characteristics and outcomes were not seen in the SAF group.<br />Trial Registry: UMIN Clinical Trials Registry; No.: UMIN000005834; URL: www.umin.ac.jp/ctr/index.htm.<br /> (Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Asymptomatic Diseases
Atrial Fibrillation complications
Atrial Fibrillation epidemiology
Cause of Death trends
Embolism epidemiology
Heart Failure epidemiology
Humans
Incidence
Japan epidemiology
Magnetic Resonance Imaging
Prevalence
Prognosis
Prospective Studies
Survival Rate trends
Tachycardia, Paroxysmal epidemiology
Tomography, X-Ray Computed
Atrial Fibrillation diagnosis
Embolism etiology
Heart Failure etiology
Registries
Risk Assessment methods
Tachycardia, Paroxysmal diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1931-3543
- Volume :
- 152
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Chest
- Publication Type :
- Academic Journal
- Accession number :
- 28823813
- Full Text :
- https://doi.org/10.1016/j.chest.2017.08.004